Diclofenac for Headache
Yes, diclofenac is indicated for treating primary headache (specifically migraine) in adults without contraindications, and should be used as first-line therapy for mild to moderate migraine attacks. 1
Evidence-Based Recommendation
The most recent 2025 American College of Physicians guideline explicitly names diclofenac as one of the recommended NSAIDs for acute episodic migraine treatment 1. Diclofenac is positioned as a first-line option alongside other NSAIDs (aspirin, celecoxib, ibuprofen, naproxen) for initial management of moderate to severe migraine headaches.
Treatment Algorithm
For mild to moderate migraine:
- Start with diclofenac or another NSAID as monotherapy
- Ensure adequate dosing before declaring treatment failure
- Consider adding acetaminophen if NSAID alone is insufficient 1
For moderate to severe migraine or inadequate NSAID response:
- Add a triptan to diclofenac (combination therapy provides superior efficacy) 1
- Begin combination therapy early in the attack for best results 1
Route selection:
- Oral diclofenac for typical presentations
- Consider non-oral routes if significant nausea/vomiting present early 1
Efficacy Data
Research demonstrates diclofenac potassium 50 mg provides:
- Pain-free at 2 hours: NNT 6.2
- Headache relief at 2 hours: NNT 8.9
- Pain-free at 24 hours: NNT 9.5 2
Newer formulations (oral solution) show even faster onset, with significant pain reduction starting at 30 minutes post-treatment and 25% of patients pain-free at 2 hours versus 10% with placebo 3.
Critical Caveats
Medication overuse threshold: Limit diclofenac use to ≤15 days per month to prevent medication-overuse headache 1. This is a higher threshold than triptans (≥10 days/month), making NSAIDs like diclofenac safer for more frequent use.
Contraindications per FDA labeling:
- Known hypersensitivity to diclofenac
- History of asthma, urticaria, or allergic reactions to aspirin or other NSAIDs
- In the setting of CABG surgery
- Cardiovascular disease requires careful risk-benefit assessment 4
Not FDA-approved specifically for headache: The FDA label indicates diclofenac for dysmenorrhea and mild-to-moderate pain generally, but does not specifically list migraine as an indication 4. However, this does not preclude its evidence-based use for migraine, which is strongly supported by clinical guidelines.
Practical Implementation
Dosing: Diclofenac potassium 50 mg is the evidence-based dose for migraine 2, 3. The choice between different diclofenac formulations (potassium vs sodium, oral solution vs tablet) should be individualized based on route preference and cost 1.
When diclofenac fails: If adequate-dose diclofenac provides insufficient relief after 2-3 headache episodes, escalate to combination therapy with a triptan rather than abandoning NSAID therapy entirely 1.
Avoid: Do not use opioids or butalbital-containing compounds for migraine treatment 1.